The Jury Is Still Out on the Benefits and Harms of Methylphenidate for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.
Clin Pharmacol Ther. 2018 10;104(4):606-609
Authors: Storebø OJ, Faltinsen E, Zwi M, Simonsen E, Gluud C
Much remains unclear about the benefits and harms of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Between 2012 and 2018, we conducted two Cochrane systematic reviews on methylphenidate for ADHD. This article explores the main findings in relation to evidence-based practice and our current understanding of ADHD.
PMID: 30006934 [PubMed – indexed for MEDLINE]